Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000182492 | SCV000234837 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2013-12-26 | criteria provided, single submitter | clinical testing | The variant is found in TAAD panel(s). |
Invitae | RCV000234421 | SCV000285776 | likely benign | Aortic aneurysm, familial thoracic 4 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001375604 | SCV001572511 | benign | not specified | 2021-04-08 | criteria provided, single submitter | clinical testing | Variant summary: MYH11 c.1596+8delG alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00021 in 250854 control chromosomes. The observed variant frequency is approximately 17 fold of the estimated maximal expected allele frequency for a pathogenic variant in MYH11 causing Thoracic Aortic Aneurysms And Dissections phenotype (1.3e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1596+8delG in individuals affected with Thoracic Aortic Aneurysms And Dissections and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV000182492 | SCV002042920 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-12-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002503708 | SCV002796730 | likely benign | Aortic aneurysm, familial thoracic 4; Visceral myopathy 2; Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 | 2021-12-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955107 | SCV004774679 | likely benign | MYH11-related condition | 2021-07-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001729434 | SCV001978115 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001729434 | SCV001980052 | likely benign | not provided | no assertion criteria provided | clinical testing |